Reviews in Endocrine and Metabolic Disorders
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

6.192

12.3%

Journal Impact IF Trend

Related Journals

Popular Journals

Reviews in Endocrine and Metabolic Disorders

The 2019-2020 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 6.192, which is just updated in 2020.

Reviews in Endocrine and Metabolic Disorders Impact Factor
Highest IF
6.192
Highest Journal Impact IF

The highest Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 6.192.

Lowest IF
3.169
Lowest Journal Impact IF

The lowest Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 3.169.

Total Growth Rate
95.4%
IF Total Growth Rate

The total growth rate of Reviews in Endocrine and Metabolic Disorders IF is 95.4%.

Annual Growth Rate
10.6%
IF Annual Growth Rate

The annual growth rate of Reviews in Endocrine and Metabolic Disorders IF is 10.6%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Endocrinology, Diabetes and Metabolism Q1 13/217

Endocrinology, Diabetes and Metabolism 94%

Endocrinology Q1 8/118

Endocrinology 93%

Journal Impact IF Ranking

· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Reviews in Endocrine and Metabolic Disorders is Q1. Reviews in Endocrine and Metabolic Disorders has been ranked #13 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Reviews in Endocrine and Metabolic Disorders is around 94% in the field of Endocrinology, Diabetes and Metabolism.
· In the Endocrinology research field, the Quartile of Reviews in Endocrine and Metabolic Disorders is Q1. Reviews in Endocrine and Metabolic Disorders has been ranked #8 over 118 related journals in the Endocrinology research category. The ranking percentile of Reviews in Endocrine and Metabolic Disorders is around 93% in the field of Endocrinology.

Reviews in Endocrine and Metabolic Disorders Impact Factor 2020-2021 Prediction

Reviews in Endocrine and Metabolic Disorders Impact Factor Predition System

Reviews in Endocrine and Metabolic Disorders Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
807
Total Citations
39913

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 6.192
2018-2019 5.516
2017-2018 4.963
2016-2017 4.817
2015-2016 5.088
2014-2015 4.892
2013-2014 3.807
2012-2013 4.583
2011-2012 3.169
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 6.192
· The 2018-2019 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 5.516
· The 2017-2018 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 4.963
· The 2016-2017 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 4.817
· The 2015-2016 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 5.088
· The 2014-2015 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 4.892
· The 2013-2014 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 3.807
· The 2012-2013 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 4.583
· The 2011-2012 Journal Impact IF of Reviews in Endocrine and Metabolic Disorders is 3.169

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1999 0 22
2000 37 56
2001 34 99
2002 37 228
2003 33 430
2004 37 604
2005 31 796
2006 1 890
2007 57 972
2008 32 1493
2009 30 1928
2010 32 2071
2011 33 2261
2012 30 2635
2013 41 2735
2014 31 2917
2015 33 2803
2016 56 2764
2017 45 3196
2018 39 2968
2019 42 3285
2020 89 4430
2021 7 330
Publications Cites Dataset

· The Reviews in Endocrine and Metabolic Disorders has published 0 reports and received 22 citations in 1999.
· The Reviews in Endocrine and Metabolic Disorders has published 37 reports and received 56 citations in 2000.
· The Reviews in Endocrine and Metabolic Disorders has published 34 reports and received 99 citations in 2001.
· The Reviews in Endocrine and Metabolic Disorders has published 37 reports and received 228 citations in 2002.
· The Reviews in Endocrine and Metabolic Disorders has published 33 reports and received 430 citations in 2003.
· The Reviews in Endocrine and Metabolic Disorders has published 37 reports and received 604 citations in 2004.
· The Reviews in Endocrine and Metabolic Disorders has published 31 reports and received 796 citations in 2005.
· The Reviews in Endocrine and Metabolic Disorders has published 1 reports and received 890 citations in 2006.
· The Reviews in Endocrine and Metabolic Disorders has published 57 reports and received 972 citations in 2007.
· The Reviews in Endocrine and Metabolic Disorders has published 32 reports and received 1493 citations in 2008.
· The Reviews in Endocrine and Metabolic Disorders has published 30 reports and received 1928 citations in 2009.
· The Reviews in Endocrine and Metabolic Disorders has published 32 reports and received 2071 citations in 2010.
· The Reviews in Endocrine and Metabolic Disorders has published 33 reports and received 2261 citations in 2011.
· The Reviews in Endocrine and Metabolic Disorders has published 30 reports and received 2635 citations in 2012.
· The Reviews in Endocrine and Metabolic Disorders has published 41 reports and received 2735 citations in 2013.
· The Reviews in Endocrine and Metabolic Disorders has published 31 reports and received 2917 citations in 2014.
· The Reviews in Endocrine and Metabolic Disorders has published 33 reports and received 2803 citations in 2015.
· The Reviews in Endocrine and Metabolic Disorders has published 56 reports and received 2764 citations in 2016.
· The Reviews in Endocrine and Metabolic Disorders has published 45 reports and received 3196 citations in 2017.
· The Reviews in Endocrine and Metabolic Disorders has published 39 reports and received 2968 citations in 2018.
· The Reviews in Endocrine and Metabolic Disorders has published 42 reports and received 3285 citations in 2019.
· The Reviews in Endocrine and Metabolic Disorders has published 89 reports and received 4430 citations in 2020.
· The Reviews in Endocrine and Metabolic Disorders has published 7 reports and received 330 citations in 2021.
· The total publications of Reviews in Endocrine and Metabolic Disorders is 807.
· The total citations of Reviews in Endocrine and Metabolic Disorders is 39913.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Reviews in Endocrine and Metabolic Disorders | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Reviews in Endocrine and Metabolic Disorders Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Reviews in Endocrine and Metabolic Disorders during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Reviews in Endocrine and Metabolic Disorders.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Reviews in Endocrine and Metabolic Disorders
Journal Profile

About

Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to students, clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field.The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice. None

Highly Cited Keywords

ISSN
1389-9155
ISSN

The ISSN of Reviews in Endocrine and Metabolic Disorders is 1389-9155 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1573-2606
ISSN (Online)

The ISSN (Online) of Reviews in Endocrine and Metabolic Disorders is 1573-2606 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Springer Netherlands
Publisher

Reviews in Endocrine and Metabolic Disorders is published by Springer Netherlands .

Publication Frequency
-
Publication Frequency

Reviews in Endocrine and Metabolic Disorders publishes reports - .

Coverage
2000 - Present
Coverage

The Publication History of Reviews in Endocrine and Metabolic Disorders covers 2000 - Present .

Open Access
NO
Open Access

Reviews in Endocrine and Metabolic Disorders is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Reviews in Endocrine and Metabolic Disorders. Reviews in Endocrine and Metabolic Disorders is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
-
Language

The language of Reviews in Endocrine and Metabolic Disorders is - .

Country/Region
Netherlands
Country/Region

The publisher of Reviews in Endocrine and Metabolic Disorders is Springer Netherlands , which locates in Netherlands .

Selected Articles

Full Title Authors
Full Title Authors
Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes Enke Baldini · Teresa Odorisio · Chiara Tuccilli · Severino Persechino · Salvatore Sorrenti · Antonio Catania · Daniele Pironi · Giovanni Carbotta · Laura Giacomelli · Stefano Arcieri · Massimo Vergine · Massimo Monti · Salvatore Ulisse · Salvatore Ulisse
Thyroid diseases and skin autoimmunity Sira Korpaisarn · Joshua D. Safer · Joshua D. Safer
Gaps in transgender medical education among healthcare providers: A major barrier to care for transgender persons Louis Gooren · Guy T’Sjoen · Guy T’Sjoen
Endocrine treatment of aging transgender people Kyoung-Jin Chung · Marina Nati · Triantafyllos Chavakis · Antonios Chatzigeorgiou · Antonios Chatzigeorgiou
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle Fady Hannah-Shmouni · Constantine A. Stratakis · Constantine A. Stratakis
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency Anna Angelousi · Gregory Kaltsas · Gregory Kaltsas · Anna Koumarianou · Martin O. Weickert · Ashley B. Grossman · Ashley B. Grossman
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature Xi-Feng Jin · Matilde Pia Spampatti · Christine Spitzweg · Christoph J. Auernhammer · Christoph J. Auernhammer
Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important Carlo Sposito · Michele Droz dit Busset · Davide Citterio · Marco Bongini · V. Mazzaferro · V. Mazzaferro
Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM) Sandra Sirrs · Larry D. Lynd · Larry D. Lynd
Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract Eldrin Bhanat · Christian A. Koch · Rinkuben Parmar · Vishnu Vardhan Garla · Vani Vijayakumar · Vani Vijayakumar
Thyroid disorders induced by checkpoint inhibitors M. Langeveld · C. E. M. Hollak · C. E. M. Hollak
Somatostatin receptor expression in non-classical locations – clinical relevance? Camilla Virili · Poupak Fallahi · Alessandro Antonelli · Salvatore Benvenga · Marco Centanni · Marco Centanni
Agreement between medical records and self-reports: Implications for transgender health research S. Ferrari · Poupak Fallahi · Fabio Galetta · Emanuele Citi · Salvatore Benvenga · Alessandro Antonelli · Alessandro Antonelli
Transgender medicine- transitioning transgender children to adulthood Joseph Gerth · Tracy A. Becerra-Culqui · Andrew Bradlyn · Darios Getahun · Enid M. Hunkeler · Timothy L. Lash · Andrea Millman · Rebecca Nash · Virginia P. Quinn · Brandi Robinson · Douglas W. Roblin · Michael J. Silverberg · Vin Tangpricha · Suma Vupputuri · Michael Goodman · Michael Goodman
Fertility preservation options in transgender people: A review Peter Herbert Kann · Peter Herbert Kann
Gut microbiota and Hashimotos thyroiditis Christian A. Koch · Stephan Petersenn · Stephan Petersenn
Cardiovascular health in transgender people Leonidas Panagiotakopoulos · Leonidas Panagiotakopoulos
Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism Christian A. Koch · Stephan Petersenn · Stephan Petersenn
When zebras run with horses – inherited metabolic diseases come mainstream Anna Nobili · Cris Glazebrook · Jon Arcelus · Jon Arcelus
Quality of life of treatment-seeking transgender adults: A systematic review and meta-analysis Michael S. Irwig · Michael S. Irwig
Innate immune cells in the adipose tissue Suzan J. G. Knottnerus · Jeannette C. Bleeker · Rob C. I. Wüst · Sacha Ferdinandusse · Lodewijk IJlst · Frits A. Wijburg · Ronald J. A. Wanders · Gepke Visser · Riekelt H. Houtkooper · Riekelt H. Houtkooper
Transgender medicine - puberty suppression Gisela Wilcox · Gisela Wilcox
Bone health in patients with inborn errors of metabolism Natnita Mattawanon · Jessica B. Spencer · David A. Schirmer · Vin Tangpricha · Vin Tangpricha
Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors Barbara Altieri · Luigi Barrea · Roberta Modica · Giovanna Muscogiuri · Silvia Savastano · Annamaria Colao · Antongiulio Faggiano · Antongiulio Faggiano
Nutrition and neuroendocrine tumors: An update of the literature Vin Tangpricha · Vin Tangpricha
Emerging topics in transgender medicine Sergio Pedraza-Arevalo · Manuel D. Gahete · Emilia Alors-Perez · Raúl M. Luque · Justo P. Castaño · Justo P. Castaño
Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors Peter E. Goretzki · Martina Mogl · Aycan Akca · Johann Pratschke · Johann Pratschke
Impact of pregnancy on inborn errors of metabolism Jessica Abramowitz · Jessica Abramowitz
Clinical aspects of changes in water and sodium homeostasis in the elderly Edgar V. Lerma · Christian A. Koch · Christian A. Koch
The role of vitamin D in male fertility: A focus on the testis Cristina de Angelis · Mariano Galdiero · Claudia Pivonello · Francesco Garifalos · Davide Menafra · Federica Cariati · Ciro Salzano · Giacomo Galdiero · Mariangela Piscopo · Alfonso Vece · Annamaria Colao · Rosario Pivonello · Rosario Pivonello
The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention Michael F. Holick · Michael F. Holick
New light on an old vitamin: The role of the sunshine vitamin D in chronic disease Christian A. Koch · Christian A. Koch
Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence Martin R. Grübler · Martin R. Grübler · Winfried März · Winfried März · Winfried März · Stefan Pilz · Stefan Pilz · Tanja B. Grammer · Christian Trummer · Christian Müllner · Verena Schwetz · Marlene Pandis · Nicolas Verheyen · Andreas Tomaschitz · Antonella Fiordelisi · Daniela Laudisio · Ersilia Cipolletta · Guido Iaccarino · Guido Iaccarino
New light on an old vitamin: The role of the sunshine vitamin D in chronic disease Giovanna Muscogiuri · Giovanna Muscogiuri
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy Christian A. Koch · Tibor Fülöp · Tibor Fülöp
Osteoporosis in patients with diabetes after kidney transplantation Elvira O. Gosmanova · Aidar R. Gosmanov · Aidar R. Gosmanov
Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism Stefania Garbossa · Franco Folli · Franco Folli · Franco Folli
Thyroid dysfunction and kidney disease: An update Pedro Iglesias · María Auxiliadora Bajo · Rafael Selgas · Juan J. Díez · Juan J. Díez
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease Zubair Ilyas · Joumana T. Chaiban · Armand Krikorian · Armand Krikorian
Current evidence on vitamin D deficiency and kidney transplant: Whats new? Gerardo Sarno · Riccardo Nappi · Barbara Altieri · Giacomo Tirabassi · Emanuele Muscogiuri · Gianmaria Salvio · Stavroula A. Paschou · Aristide Ferrara · E. Russo · Daniela Vicedomini · Cerbone Vincenzo · Andromachi Vryonidou · Silvia Della Casa · Giancarlo Balercia · Francesco Orio · Paride De Rosa · Paride De Rosa
Low vitamin D status and obesity: Role of nutritionist Silvia Savastano · Luigi Barrea · Maria Cristina Savanelli · Francesca Nappi · Carolina Di Somma · Francesco Orio · Annamaria Colao · Annamaria Colao
The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms Meis Moukayed · William B. Grant · William B. Grant
Vitamin D: Musculoskeletal health Harjit Pal Bhattoa · Jerzy Konstantynowicz · Natalia Laszcz · Marek Wójcik · Pawel Pludowski · Pawel Pludowski
Dyslipidemia in patients with chronic kidney disease Matthew R. Hager · Archana D. Narla · Lisa R. Tannock · Lisa R. Tannock
Vitamin D and diabetes mellitus: Causal or casual association? Maria Grammatiki · Eleni Rapti · S. Karras · Ramzi Ajjan · Kalliopi Kotsa · Kalliopi Kotsa
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept Barbara Altieri · Giovanna Muscogiuri · Luigi Barrea · Chantal Mathieu · Carla V. Vallone · Luca Mascitelli · Giorgia Bizzaro · Vincenzo Maria Altieri · Giacomo Tirabassi · Giancarlo Balercia · Silvia Savastano · Nicola Bizzaro · Cristina L. Ronchi · Annamaria Colao · Alfredo Pontecorvi · Silvia Della Casa · Silvia Della Casa
Shedding new light on female fertility: The role of vitamin D Giovanna Muscogiuri · Barbara Altieri · Cristina de Angelis · Stefano Palomba · Rosario Pivonello · Annamaria Colao · Francesco Orio · Francesco Orio
Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy Triona O’Shea · Maralyn Druce · Maralyn Druce
Chemotherapy in NETs: When and how Teresa Amaral · Ulrike Leiter · Claus Garbe · Claus Garbe
Gonadal dysfunction in chronic kidney disease Biff F. Palmer · Deborah J. Clegg · Deborah J. Clegg
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist Luigi Barrea · Maria Cristina Savanelli · Carolina Di Somma · Maddalena Napolitano · Matteo Megna · Annamaria Colao · Silvia Savastano · Silvia Savastano
Updates in hyperkalemia: Outcomes and therapeutic strategies Csaba P. Kovesdy · Csaba P. Kovesdy
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison Luigi Barrea · Silvia Savastano · Carolina Di Somma · Maria Cristina Savanelli · Francesca Nappi · Lidia Albanese · Francesco Orio · Annamaria Colao · Annamaria Colao
Editorial: Neuroendocrine neoplasms Stephan Petersenn · Christian A. Koch · Christian A. Koch
X-linked hypophosphatemia and growth R. Fuente · H. Gil-Peña · Debora Claramunt-Taberner · O. Hernández · A. Fernández-Iglesias · L. Alonso-Durán · E. Rodríguez-Rubio · Fernando Santos · Fernando Santos
Sunshine vitamin and thyroid Immacolata Cristina Nettore · Luigi Albano · Paola Ungaro · Annamaria Colao · Paolo Emidio Macchia · Paolo Emidio Macchia
Adrenal disorders: Is there Any role for vitamin D? Giacomo Tirabassi · Gianmaria Salvio · Barbara Altieri · Cristina L. Ronchi · Silvia Della Casa · Alfredo Pontecorvi · Giancarlo Balercia · Giancarlo Balercia
Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines Roseanne O. Yeung · Fady Hannah-Shmouni · Karen Y Niederhoffer · M. Walker · M. Walker
Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies Mariano Rodríguez Portillo · María E. Rodríguez-Ortiz · María E. Rodríguez-Ortiz
Nephroendocrinology: When endocrinology meets nephrology Michel Tchan · Michel Tchan · Michel Tchan
The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons Andre Mattman · Murray Potter · Murray Potter
Hyponatremia and bone disease Armando Luis Negri · Juan Carlos Ayus · Juan Carlos Ayus
Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose? Silvia Fabiani · Poupak Fallahi · Silvia Martina Ferrari · Mario Miccoli · Alessandro Antonelli · Alessandro Antonelli
Cyto-histology in NET: what is necessary today and what is the future? Christian Fottner · Martina Ferrata · Martina Ferrata · Matthias M. Weber · Matthias M. Weber
Management of neuroendocrine tumors of unknown primary Frediano Inzani · Gianluigi Petrone · Guido Fadda · Guido Rindi · Guido Rindi
Correction to: X-linked hypophosphatemia and growth Krystallenia I. Alexandraki · Anna Angelousi · Georgios Boutzios · Georgios Kyriakopoulos · Dimitra Rontogianni · Gregory Kaltsas · Gregory Kaltsas
Is there any role for minimally invasive surgery in NET R. Fuente · H. Gil-Peña · Debora Claramunt-Taberner · O. Hernández · A. Fernández-Iglesias · L. Alonso-Durán · E. Rodríguez-Rubio · Fernando Santos · Fernando Santos
Echocardiography in functional midgut neuroendocrine tumors: When and how often M. Thomaschewski · H. Neeff · Tobias Keck · Hartmut P. H. Neumann · Tim Strate · E. von Dobschuetz · E. von Dobschuetz
Management of pulmonary neuroendocrine tumors Javier G. Castillo · Tara Naib · Jerome S. Zacks · David H. Adams · David H. Adams
Liver transarterial embolizations in metastatic neuroendocrine tumors Robert A. Ramirez · Aman Chauhan · Juan Gimenez · Katharine E. H. Thomas · Ioni M. Kokodis · Brianne A. Voros · Brianne A. Voros
When should genetic testing be performed in patients with neuroendocrine tumours Louis de Mestier · Magaly Zappa · Olivia Hentic · Valérie Vilgrain · Philippe Ruszniewski · Philippe Ruszniewski
A journey from brain to muscle across the thyroid continent Salvatore Benvenga · Salvatore Benvenga
Editorial: A journey from brain to muscle across the thyroid continent Christian A. Koch · Christian A. Koch
Beyond acne: Current aspects of sebaceous gland biology and function Christos C. Zouboulis · Mauro Picardo · Qiang Ju · Ichiro Kurokawa · Dániel Törőcsik · Tamás Bíró · Marlon R. Schneider · Marlon R. Schneider
Determinants of mortality in patients with type 2 diabetes: a review Jana Engelmann · Ulf Manuwald · Constanze Rubach · Joachim Kugler · Andreas L. Birkenfeld · Markolf Hanefeld · Ulrike Rothe · Ulrike Rothe
Skin manifestations of Cushings syndrome Constantine A. Stratakis · Constantine A. Stratakis
Carney complex: A familial lentiginosis predisposing to a variety of tumors Constantine A. Stratakis · Constantine A. Stratakis
Neuroendocrinology of the skin Theoharis C. Theoharides · Julia M. Stewart · Alexandra Taracanova · Pio Conti · Christos C. Zouboulis · Christos C. Zouboulis
Endocrine-disrupting chemicals and skin manifestations Qiang Ju · Christos C. Zouboulis · Christos C. Zouboulis
Stress-related skin disorders Alex Alexopoulos · George P. Chrousos · George P. Chrousos
Male fertility and skin diseases M. Badawy Abdel-Naser · Christos C. Zouboulis · Christos C. Zouboulis
Inositol(s) in thyroid function, growth and autoimmunity Salvatore Benvenga · Alessandro Antonelli · Alessandro Antonelli
Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Ioannis Karagiannidis · Georgios Nikolakis · Robert Sabat · Christos C. Zouboulis · Christos C. Zouboulis
Molecular mimicry and autoimmune thyroid disease Salvatore Benvenga · Fabrizio Guarneri · Fabrizio Guarneri
The effects of indoor and outdoor temperature on metabolic rate and adipose tissue - the Mississippi perspective on the obesity epidemic J. B. Turner · A. Kumar · Christian A. Koch · Christian A. Koch
Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome D. I. Siegel-Axel · H. U. Häring · H. U. Häring
Glucose variability, HbA1c and microvascular complications Jan Škrha · Jan Šoupal · Martin Prázný · Martin Prázný
The metabolic vascular syndrome - guide to an individualized treatment Markolf Hanefeld · Frank Pistrosch · Stefan R. Bornstein · Andreas L. Birkenfeld · Andreas L. Birkenfeld
Understanding the Metabolic and Health Effects of Low-calorie Sweeteners: Methodological Considerations and Implications for Future Research Allison C. Sylvetsky · Allison C. Sylvetsky · Jenny E. Blau · Kristina I. Rother · Kristina I. Rother
Cardiometabolic crosstalk in obesity-associated arterial hypertension Jens Jordan · Andreas L. Birkenfeld · Andreas L. Birkenfeld
The role of innate immunity in the regulation of brown and beige adipogenesis Vasileia Ismini Alexaki · Triantafyllos Chavakis · Triantafyllos Chavakis
Atherogenicity of postprandial hyperglycemia and lipotoxicity Antonio Ceriello · Stefano Genovese · Stefano Genovese
The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH) Marina Nati · David Haddad · Andreas L. Birkenfeld · Andreas L. Birkenfeld · Christian A. Koch · Triantafyllos Chavakis · Antonios Chatzigeorgiou · Antonios Chatzigeorgiou
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa Wayne Gulliver · Christos C. Zouboulis · Errol P. Prens · Gregor B. E. Jemec · Thrasivoulos Tzellos · Thrasivoulos Tzellos
Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes Avivit Cahn · Simona Cernea · Itamar Raz · Itamar Raz
Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory Jane Shearer · Susan E. Swithers · Susan E. Swithers
Oral sensory nerve damage: Causes and consequences Derek J. Snyder · Linda M. Bartoshuk · Linda M. Bartoshuk
Diabetes mellitus and the skin Evgenia Makrantonaki · D. Jiang · Amir M. Hossini · Georgios Nikolakis · M. Wlaschek · Karin Scharffetter-Kochanek · Christos C. Zouboulis · Christos C. Zouboulis
The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders Poupak Fallahi · Silvia Martina Ferrari · Roberto Vita · Salvatore Benvenga · Alessandro Antonelli · Alessandro Antonelli
Hereditary syndromes predisposing to endocrine tumors and their skin manifestations Constantine A. Stratakis · Constantine A. Stratakis
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy Louis Monnier · Claude Colette · Sylvie Dejager · David Raymond Owens · David Raymond Owens
The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution Antonio Ieni · Valeria Barresi · Roberta Cardia · Luana Licata · Flavia Di Bari · Salvatore Benvenga · Giovanni Tuccari · Giovanni Tuccari
Biomarkers of skin aging Theodora Kanaki · Evgenia Makrantonaki · Christos C. Zouboulis · Christos C. Zouboulis
Flushing in (neuro)endocrinology Fady Hannah-Shmouni · Constantine A. Stratakis · Christian A. Koch · Christian A. Koch
Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer K. Karimi · T. H. Lindgren · Christian A. Koch · Robert T. Brodell · Robert T. Brodell · Robert T. Brodell
Skin steroidogenesis in health and disease Georgios Nikolakis · Constantine A. Stratakis · Theodora Kanaki · Andrej Slominski · Christos C. Zouboulis · Christos C. Zouboulis
Endocrine manifestations of systemic mastocytosis in bone Loren Wissner Greene · Kamyar Asadipooya · Patricia Freitas Corradi · Cem Akin · Cem Akin
Recent advances in the modification of taste and food preferences following bariatric surgery Stefany D. Primeaux · Stefany D. Primeaux · Taniya de Silva · Tony H. Tzeng · Monica C. Chiang · Daniel S. Hsia · Daniel S. Hsia · Daniel S. Hsia
New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction Howard J. Hoffman · Shristi Rawal · Shristi Rawal · Chuan-Ming Li · Valerie B. Duffy · Valerie B. Duffy
The development of sweet taste: From biology to hedonics Julie A. Mennella · Nuala Bobowski · Danielle R. Reed · Danielle R. Reed
Introduction to Hanefeld Symposium: 40+ years of metabolic syndrome Christian A. Koch · Stefan R. Bornstein · Stefan R. Bornstein · Andreas L. Birkenfeld · Andreas L. Birkenfeld
Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers Christoph Langenstein · Diana Schork · Klaus Badenhoop · Eva Herrmann · Eva Herrmann
Conservation in the phylum of the local homology of apolipoproteins with the thyroid hormone plasma carriers Salvatore Benvenga · Fabrizio Guarneri · Fabrizio Guarneri
Introduction to the sense of taste in endocrinology Christian A. Koch · Christian A. Koch
Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations Kerstin Wolk · Robert Sabat · Robert Sabat
Access, availability, and infrastructure deficiency: The current management of thyroid disease in the developing world Jane Fualal · Joel Ehrenkranz · Joel Ehrenkranz
Skin manifestations of growth hormone-induced diseases Christina Kanaka-Gantenbein · Christina Kogia · Mohamed Badawy Abdel-Naser · George P. Chrousos · George P. Chrousos
Thyroid hormone regulation of adult intestinal stem cells: Implications on intestinal development and homeostasis Guihong Sun · Julia Roediger · Yun-Bo Shi · Yun-Bo Shi
Advances in TRH signaling Patricia Joseph-Bravo · Lorraine Jaimes-Hoy · Jean-Louis Charli · Jean-Louis Charli
EDITORIAL:The Kochsview on the sense of taste in endocrinology Christian A. Koch · Christian A. Koch
Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook Jörg Reichrath · Christos C. Zouboulis · Thomas Vogt · Michael F. Holick · Michael F. Holick
Metabolism and skin diseases Christos C. Zouboulis · Constantine A. Stratakis · George P. Chrousos · Christian A. Koch · Christian A. Koch
Lipids and obesity: Also a matter of taste? Philippe Besnard · Philippe Besnard
Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature Alessandro Sindoni · Carmelo Rodolico · Maria Angela Pappalardo · Simona Portaro · Salvatore Benvenga · Salvatore Benvenga
A Genome-Wide Association Study in isolated populations reveals new genes associated to common food likings Nicola Pirastu · Maarten Kooyman · Michela Traglia · Antonietta Robino · Sara M. Willems · Giorgio Pistis · Najaf Amin · Cinzia Sala · Lennart C. Karssen · Cornelia van Duijn · Cornelia van Duijn · Daniela Toniolo · Paolo Gasparini · Paolo Gasparini
Interventional treatment of obesity and diabetes: An interim report on gastric electrical stimulation Harold E. Lebovitz · Harold E. Lebovitz
Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism Steven K. Malin · Zhenqi Liu · Eugene J. Barrett · Arthur Weltman · Arthur Weltman

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes
Reviews in Endocrine and Metabolic Disorders | 2018
Enke Baldini · Teresa Odorisio · Chiara Tuccilli · Severino Persechino · Salvatore Sorrenti · Antonio Catania · Daniele Pironi · Giovanni Carbotta · Laura Giacomelli · Stefano Arcieri · Massimo Vergine · Massimo Monti · Salvatore Ulisse · Salvatore Ulisse
Endocrine treatment of aging transgender people
Reviews in Endocrine and Metabolic Disorders | 2018
Kyoung-Jin Chung · Marina Nati · Triantafyllos Chavakis · Antonios Chatzigeorgiou · Antonios Chatzigeorgiou